@comment{ WHO: Dementia: A Public Health Priority. Geneva; 2012:112.  }
@book{prioritygeneva,
 author = "Geneva",
 title = "WHO: Dementia: A Public Health Priority",
 year = "2012:112"
}

 @comment{ Reitz, C., Brayne, C. & Mayeux, R. Epidemiology of Alzheimer 
           disease. Nature reviews. Neurology 7, 137–152 (2011).  }
@article{reitz2011epidemiology,
 author = "Reitz, C. and Brayne, C. and Mayeux, R.",
 title = "Epidemiology of {Alzheimer} disease",
 journal = "Nature reviews. {Neurology}",
 volume = "7",
 year = 2011
}

 @comment{ Glenner, G. G. & Wong, C. W. (1984). Alzheimer's disease: initial 
           report of the purificationand characterization of a novel 
           cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 
           120, 885–890.  }
@article{glenner1984alzheimers,
 author = "Glenner, G. G. and Wong, C. W.",
 title = "Alzheimer's disease: initial report of the purificationand characterization of a novel cerebrovascular amyloid protein",
 journal = "Biochem. Biophys. Res. Commun",
 volume = "120",
 year = 1984
}

 @comment{ Swerdlow, RH., Khan, SM. (2004) A "mitochondrial cascade hypothesis" 
           for sporadic Alzheimer's disease. Med Hypotheses 63: 8-20.  }
@article{rh2004mitochondrial,
 author = "Swerdlow, RH. and Khan, SM.",
 title = "A mitochondrial cascade hypothesis for sporadic {Alzheimer}'s disease",
 journal = "Med Hypotheses",
 volume = "63",
 pages = "8--20",
 year = 2004
}

@article{ahu61,
       author={Arrow, Kenneth J. and Leonid Hurwicz and Hirofumi Uzawa},
       title={Constraint qualifications in maximization problems},
       journal={Naval Research Logistics Quarterly},
       volume={8},
       year = 1961,
       pages = {175-191}
     }

 @comment{ Ridge PG, Maxwell TJ, Corcoran CD, Norton MC, Tschanz JT, et al. 
           (2012) Mitochondrial Genomic Analysis of Late Onset Alzheimer’s 
           Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache 
           County Study on Memory in Aging. PLoS ONE 7(9): e45134. doi:10.1371  }

@article{pg2012,
 author = "Ridge, PG. and Maxwell, TJ. and Corcoran, CD. and Norton, MC. and Tschanz, JT. and others",
 title = "Mitochondrial Genomic Analysis of Late Onset Alzheimer's Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging",
 journal = "PLoS {ONE}",
 volume = "",
 number = "1371",
 year = "2012"
}

 @comment{ Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) 
           Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease 
           risk loci and reveals interactions with APOE genotypes. Arch Neurol 
           67: 1473-1484.  }

@article{ac2010,
 author = "Jun, G and Naj, AC and Beecham, GW and Wang, LS and Buros, J and others",
 title = "{Meta}-analysis confirms {CR}1, {CLU}, and {PICALM} as alzheimer disease risk loci and reveals interactions with {APOE} genotypes",
 journal = "Arch Neurol",
 volume = "67",
 pages = "1473--1484",
 year = "2010"
}

 @comment{ Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. 
           (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and 
           CD2AP are associated with Alzheimer's disease. Nat Genet 43: 
           429-435.  }

@article{jc2011,
 author = "Hollingworth, P and Harold, D and Sims, R and Gerrish, A and Lambert, JC and others",
 title = "{Common} variants at {ABCA}7, {MS}4A6A/MS4A4E, {EPHA}1, {CD}33 and {CD}2AP are associated with {Alzheimer}'s disease",
 journal = "Nat Genet",
 volume = "43",
 pages = "429--435",
 year = "2011"
}

 @comment{ Mahley R, et al. (2009). Apolipoprotein E: structure determines 
           function, from atherosclerosis to Alzheimer's disease to AIDS. 
           Journal of lipid research. available at www.jlr.org  }

@article{Mahley2009,
 author = "Mahley, R and others",
 title = "Apolipoprotein {E}: structure determines function, from atherosclerosis to {Alzheimer}'s disease to {AIDS}",
 journal = "Journal of lipid research.",
 year = "2009"
}

 @comment{ Hulstaert, F. et al. (1999). Improved discrimination of AD patients 
           using ß-amyloid(1–42) and tau levels in CSF. Neurology 52, 
           1555–1562.  }

@article{hulstaert1999,
 author = "Hulstaert, F. and others",
 title = "Improved discrimination of {AD} patients using beta-amyloid 42 and tau levels in {CSF}",
 journal = "{Neurology}",
 volume = "52",
 year = "1999"
}

 @comment{ Klunk, W.E. et al. (2004). Imaging brain amyloid in Alzheimer's 
           disease with Pittsburgh Compound-B.Ann. Neurol. 55, 306–319  }

@article{klunk2004,
 author = "Klunk, W. E. and others",
 title = "Imaging brain amyloid in {Alzheimer}'s disease with {Pittsburgh} {Compound}-{B}",
 journal = "{Ann}. {Neurol}",
 volume = "55",
 year = 
}

 @comment{ Swainson R, et al. (2001). Early Detection and Differential 
           Diagnosis of Alzheimer's Disease and Depression with 
           Neuropsychological Tasks. Dement Geriatr Cogn Disord. 12:265–280 
           (DOI:10.1159/000051269)  }

@article{swa2001,
 author = "Swainson, R. and others",
 title = "Early Detection and Differential Diagnosis of Alzheimer's Disease and Depression with Neuropsychological Tasks",
 journal = "Dement Geriatr Cogn Disord.",
 publisher = "10",
 volume = "12:265-280 (DOI:10.1159/000051269)",
 year = "2001"
}

 @comment{ Bennett P. (2003). Early Diagnosis of Alzheimer's Disease: Clinical 
           and Economic Benefits. Journal of the American Geriatrics Society. 
           Volume 51, Issue 5s2, pages S281–S288  }

@article{2003early,
 author = "Bennett, P.",
 title = "Early Diagnosis of Alzheimer's Disease: Clinical and Economic Benefits",
 journal = "Journal of the American Geriatrics Society",
 volume = "51",
 year = 2003
}

 @comment{ Yang E, et al. (2011). Quantifying the Pathophysiological Timeline 
           of Alzheimer's Disease. Journal of Alzheimer's Disease. 26: 
           745–753 745 DOI 10.3233/JAD-2011-110551  }

@article{Yang2011,
 author = "Yang, E. and others",
 title = "Quantifying the Pathophysiological Timeline of Alzheimer's Disease",
 journal = "Journal of Alzheimer's Disease. 26:745-753",
 volume = "745",
 year = 2011
}

 @comment{ Delor I, et al. (2013). Modeling Alzheimer's Disease Progression 
           Using Disease Onset Time and Disease Trajectory Concepts Applied to 
           CDR-SOB Scores From ADNI. CPT Pharmacometrics Syst. Pharmacol. 2, 
           e78; doi:10.1038  }


@article{delor2013,
 author = "Delor, I and others",
 title = "Modeling {Alzheimer}'s {Disease} {Progression} {Using} {Disease} {Onset} {Time} and {Disease} {Trajectory} {Concepts} {Applied} to {CDR}-{SOB} {Scores} {From} {ADNI}",
 journal = "{CPT} {Pharmacometrics} {Syst}. {Pharmacol}. 2, e78; doi:10",
 volume = "2",
 number = "1038",
 year = 
}

 @comment{ Mapstone M, et al. (2014). Plasma phospholipids identify antecedent 
           memory impairment in older adults. Nature Medicine. 
           doi:10.1038/nm.3466  }

@book{map2014,
 author = "Mapstone, M. and others",
 title = "Plasma phospholipids identify antecedent memory impairment in older adults",
 publisher = "Nature Medicine",
 year = 
}

@article{lambert2013meta,
  title={Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease},
  author={Lambert, Jean-Charles and Ibrahim-Verbaas, Carla A and Harold, Denise and Naj, Adam C and Sims, Rebecca and Bellenguez, C{\'e}line and Jun, Gyungah and DeStefano, Anita L and Bis, Joshua C and Beecham, Gary W and others},
  journal={Nature genetics},
  year={2013},
  publisher={Nature Publishing Group}
}
